RGEN Q1 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$45M+46.6% YoY

Gross Profit

$25M56.1% margin

Operating Income

$6M13.3% margin

Net Income

$3M7.7% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+7.7%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$8,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$743M

Total Liabilities

$146M

Stockholders' Equity

$597M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$31M	+46.6%
Gross Profit	$25M	$17M	+51.6%
Operating Income	$6M	$6M	+5.3%
Net Income	$3M	$3M	+12.4%

Geographic Segments

North America

$20M45%

Europe

$19M43%

Asia Pacific

$5M11%

All Other

$243,0001%